Interleukin-6 plasma levels are modulated by a polymorphism in theNF-κB1gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-6 plasma levels are modulated by a polymorphism in theNF-κB1gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma
Authors
Keywords
-
Journal
LEUKEMIA & LYMPHOMA
Volume 53, Issue 3, Pages 411-416
Publisher
Informa UK Limited
Online
2011-09-10
DOI
10.3109/10428194.2011.621566
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium
- (2011) G. Salles et al. BLOOD
- Cytokine polymorphisms in Th1/Th2 pathway genes, body mass index, and risk of non-Hodgkin lymphoma
- (2010) Y. Chen et al. BLOOD
- The host genetic background of DNA repair mechanisms is an independent predictor of survival in diffuse large B-cell lymphoma
- (2010) D. Rossi et al. BLOOD
- Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
- (2010) G. Ott et al. BLOOD
- Polymorphisms in NFkB, PXR, LXR and risk of colorectal cancer in a prospective study of Danes
- (2010) Vibeke Andersen et al. BMC CANCER
- Common studied polymorphisms do not affect plasma cytokine levels upon endotoxin exposure in humans
- (2010) S. Taudorf et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+B-Cell Lymphoma in the Rituximab Era
- (2010) Marita Ziepert et al. JOURNAL OF CLINICAL ONCOLOGY
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A polymorphism in NFKB1 is associated with improved effect of interferon- maintenance treatment of patients with multiple myeloma after high-dose treatment with stem cell support
- (2009) A. J. Vangsted et al. HAEMATOLOGICA
- Analysis of the host pharmacogenetic background for prediction of outcome and toxicity in diffuse large B-cell lymphoma treated with R-CHOP21
- (2009) D Rossi et al. LEUKEMIA
- Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma
- (2009) Stefan Hohaus et al. LEUKEMIA RESEARCH
- Soluble interleukin-2 receptor retains prognostic value in patients with diffuse large B-cell lymphoma receiving rituximab plus CHOP (RCHOP) therapy
- (2008) D. Ennishi et al. ANNALS OF ONCOLOGY
- Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era
- (2008) T. M. Habermann et al. BLOOD
- Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma
- (2008) Johan Linderoth et al. BRITISH JOURNAL OF HAEMATOLOGY
- Genetic Variation in Tumor Necrosis Factor and the Nuclear Factor- B Canonical Pathway and Risk of Non-Hodgkin's Lymphoma
- (2008) J. R. Cerhan et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Effect of Interleukin-10 Gene Polymorphisms on Clinical Outcome of Patients with Aggressive Non-Hodgkin's Lymphoma: An Exploratory Study
- (2008) D. Kube et al. CLINICAL CANCER RESEARCH
- Cytokine and cytokine receptor gene polymorphisms and their functionality
- (2008) Andrew J.P. Smith et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now